Topics

Cholesteryl ester storage disease: endoscopic findings of an orphan disease.

08:00 EDT 11th October 2019 | BioPortfolio

Summary of "Cholesteryl ester storage disease: endoscopic findings of an orphan disease."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: Endoscopy
ISSN: 1438-8812
Pages:

Links

DeepDyve research library

PubMed Articles [28761 Associated PubMed Articles listed on BioPortfolio]

Human Meibum Cholesteryl and Wax Ester Variability With Age, Sex, and Meibomian Gland Dysfunction.

Relationships between tear film lipid (TFL) layer composition, structure, and function could provide insight into the etiology of dry eye. The molar ratio of cholesteryl ester (CE)/wax ester (WE) was ...

The association of genetic variants in cholesteryl ester transfer protein with haemostatic factors and a first venous thrombosis.

Cholesteryl ester transfer protein (CETP) plays an important role in lipoprotein metabolism. Previous studies suggested that the CETP TaqI B1/B2 allele is associated with the risk of venous thrombosis...

"Management of Cushing's disease: Changing trend from microscopic to endoscopic surgery".

Cushing's disease (CD) is a spectrum of clinical manifestations due to ACTH-secreting pituitary adenoma. Transsphenoidaladenomectomy remains the standard treatment. There is a paradigm shift from micr...

Fecal Calprotectin as a Screening Marker for Inflammatory Bowel Disease.

We compared fecal calprotectin and endoscopic findings of 53 children with possible inflammatory bowel disease and found an optimal cut-off of 68 µg/g in Receiver operative curve [AUC 0.88 (95% CI 0....

Hepatic glycogen storage diseases are associated to microbial dysbiosis.

The gut microbiome has been related to several features present in Glycogen Storage Diseases (GSD) patients including obesity, inflammatory bowel disease (IBD) and liver disease.

Clinical Trials [21694 Associated Clinical Trials listed on BioPortfolio]

National Lysosomal Acid Lipase Deficiency Study

Cholesteryl Ester Storage Disease (CESD) is an autosomal recessive lysosomal storage disorder (LSD) caused by mutations in the lysosomal acid lipase gene (LIPA) that markedly reduce lysoso...

Cholesterol Metabolism and Lipid Transfer in Diabetes

The diabetic dyslipidemia is one of the most important risk factor in the development of coronary artery disease. The low density lipoprotein (LDL)-like nanoemulsions is being used to stud...

Study of Glycogen Storage Disease and Associated Disorders

Glycogen, is the storage form of glucose. It is usually formed from sugar and stored in the liver. When tissues, such as muscle, need glucose for fuel the stored glycogen is converted in...

International Registry Study of Neutral Lipid Storage Disease and Related Diseases

This study aims to understand the state of onset of NLSD(neutral lipid storage disease) / TGCV(triglyceride deposit cardiovasculopathy) worldwide, background information of affected patien...

Genetic Studies of Lysosomal Storage Disorders

The purpose of this study is to identify genetic, biochemical, and clinical factors that are associated with disease severity in people with Gaucher disease and other lysosomal storage dis...

Medical and Biotech [MESH] Definitions

The severe infantile form of inherited lysosomal lipid storage diseases due to deficiency of acid lipase (STEROL ESTERASE). It is characterized by the accumulation of neutral lipids, particularly CHOLESTEROL ESTERS in leukocytes, fibroblasts, and hepatocytes. It is also known as Wolman's xanthomatosis and is an allelic variant of CHOLESTEROL ESTER STORAGE DISEASE.

A superfamily of large integral ATP-binding cassette membrane proteins whose expression pattern is consistent with a role in lipid (cholesterol) efflux. It is implicated in TANGIER DISEASE characterized by accumulation of cholesteryl ester in various tissues.

An autosomal recessive disorder caused by mutations in the gene for acid lipase (STEROL ESTERASE). It is characterized by the accumulation of neutral lipids, particularly CHOLESTEROL ESTERS in leukocytes, fibroblasts, and hepatocytes.

An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system). The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups Type IIIa and Type IIIb being the most prevalent.

A hepatic GLYCOGEN STORAGE DISEASE in which there is an apparent deficiency of hepatic phosphorylase (GLYCOGEN PHOSPHORYLASE, LIVER FORM) activity.

Quick Search


DeepDyve research library

Searches Linking to this Article